These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2612495)

  • 1. Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy.
    Binnie CD; Debets RM; Engelsman M; Meijer JW; Meinardi H; Overweg J; Peck AW; Van Wieringen A; Yuen WC
    Epilepsy Res; 1989; 4(3):222-9. PubMed ID: 2612495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures.
    Loiseau P; Yuen AW; Duché B; Ménager T; Arné-Bès MC
    Epilepsy Res; 1990 Nov; 7(2):136-45. PubMed ID: 2127016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of lamotrigine (Lamictal) for treatment-resistant partial seizures.
    Boas J; Dam M; Friis ML; Kristensen O; Pedersen B; Gallagher J
    Acta Neurol Scand; 1996 Oct; 94(4):247-52. PubMed ID: 8937535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures.
    Jawad S; Richens A; Goodwin G; Yuen WC
    Epilepsia; 1989; 30(3):356-63. PubMed ID: 2498073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy.
    Sander JW; Patsalos PN; Oxley JR; Hamilton MJ; Yuen WC
    Epilepsy Res; 1990 Aug; 6(3):221-6. PubMed ID: 2272345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group.
    Duchowny M; Pellock JM; Graf WD; Billard C; Gilman J; Casale E; Womble G; Risner M; Manasco P
    Neurology; 1999 Nov; 53(8):1724-31. PubMed ID: 10563619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures.
    Schapel GJ; Beran RG; Vajda FJ; Berkovic SF; Mashford ML; Dunagan FM; Yuen WC; Davies G
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):448-53. PubMed ID: 8505632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy.
    Beran RG; Berkovic SF; Dunagan FM; Vajda FJ; Danta G; Black AB; Mackenzie R
    Epilepsia; 1998 Dec; 39(12):1329-33. PubMed ID: 9860069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group.
    Matsuo F; Bergen D; Faught E; Messenheimer JA; Dren AT; Rudd GD; Lineberry CG
    Neurology; 1993 Nov; 43(11):2284-91. PubMed ID: 8232944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study.
    Eriksson AS; Nergårdh A; Hoppu K
    Epilepsia; 1998 May; 39(5):495-501. PubMed ID: 9596201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis.
    Breuer B; Pappagallo M; Knotkova H; Guleyupoglu N; Wallenstein S; Portenoy RK
    Clin Ther; 2007 Sep; 29(9):2022-30. PubMed ID: 18035201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.
    Motte J; Trevathan E; Arvidsson JF; Barrera MN; Mullens EL; Manasco P
    N Engl J Med; 1997 Dec; 337(25):1807-12. PubMed ID: 9400037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy.
    Goa KL; Ross SR; Chrisp P
    Drugs; 1993 Jul; 46(1):152-76. PubMed ID: 7691504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seven day administration of lamotrigine in epilepsy: placebo-controlled add-on trial.
    Binnie CD; Beintema DJ; Debets RM; Van Emde Boas W; Meijer JW; Meinardi H; Peck AW; Westendorp AM; Yuen WC
    Epilepsy Res; 1987 May; 1(3):202-8. PubMed ID: 3332866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial.
    Messenheimer J; Ramsay RE; Willmore LJ; Leroy RF; Zielinski JJ; Mattson R; Pellock JM; Valakas AM; Womble G; Risner M
    Epilepsia; 1994; 35(1):113-21. PubMed ID: 8112232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine. A review of its use in childhood epilepsy.
    Culy CR; Goa KL
    Paediatr Drugs; 2000; 2(4):299-330. PubMed ID: 10946418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
    Fitton A; Goa KL
    Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial.
    Privitera MD; Welty TE; Gidal BE; Diaz FJ; Krebill R; Szaflarski JP; Dworetzky BA; Pollard JR; Elder EJ; Jiang W; Jiang X; Berg M
    Lancet Neurol; 2016 Apr; 15(4):365-72. PubMed ID: 26875743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
    Ting TY; Jiang W; Lionberger R; Wong J; Jones JW; Kane MA; Krumholz A; Temple R; Polli JE
    Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.